Literature DB >> 6338678

Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism.

K Polonsky, J Jaspan, D Emmanouel, K Holmes, A R Moossa.   

Abstract

The metabolism of exogenously infused porcine insulin and glucagon was assessed concurrently in normal fasted dogs under anaesthesia. Hepatic and renal extraction of glucagon were 25.6 +/- 2.3 and 43.7 +/- 3.9%, respectively, and its metabolic clearance 16.5 +/- 0.8 ml/kg/min. Hepatic and renal extraction accounted for 28.5 +/- 4.2 and 28.7 +/- 3.7% of total glucagon clearance, respectively. Insulin MCR was 18.3 +/- 1.5 ml/kg/min and its hepatic and renal extraction were 49.6 +/- 3.4 and 41.7 +/- 4.4% accounting for 51.9 +/- 4.4 and 27.3 +/- 3.9% of total insulin clearance, respectively. Neither total glucagon metabolic clearance nor its hepatic or renal components saturated even in the face of circulating glucagon levels extending into the pharmacologic range up to 14 ng/ml. In contrast however, with increasing arterial concentrations of insulin, saturability of metabolism was apparent as evidenced by significant reductions in MCR as well as hepatic and renal extraction. This demonstration of saturability of hepatic insulin metabolism occurred at levels encountered in the portal vein after meals and is compatible with the concept that the hepatic capacity for extraction of this hormone may be an important site of control of the proportion of secreted insulin reaching the periphery. The metabolic handling of each hormone was shown to be independent of the other. Despite similarities in the interaction of insulin and glucagon with the target cell, there are important differences in the mechanisms of metabolism of these peptides as the major degradative sites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338678     DOI: 10.1530/acta.0.1020420

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  18 in total

1.  Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo.

Authors:  S R Myers; D W Biggers; D W Neal; A D Cherrington
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 2.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

3.  Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver.

Authors:  H Sato; T Terasaki; H Mizuguchi; K Okumura; A Tsuji
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

4.  Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.

Authors:  S D Mittelman; Y Y Fu; K Rebrin; G Steil; R N Bergman
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

5.  C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

Authors:  K S Polonsky; W Pugh; J B Jaspan; D M Cohen; T Karrison; H S Tager; A H Rubenstein
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

6.  Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model.

Authors:  S E Shoelson; K S Polonsky; A Zeidler; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

7.  Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.

Authors:  P De Feo; G Perriello; M M Ventura; F Calcinaro; G Basta; C Lolli; C Cruciani; A Dell'Olio; F Santeusanio; P Brunetti
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

8.  The measurement and validation of the nonsteady-state rates of C-peptide appearance in the dog.

Authors:  T Morishima; S Pye; K Polonsky; J Radziuk
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

Review 9.  The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

10.  Insulin Wakayama: familial mutant insulin syndrome in Japan.

Authors:  K Nanjo; M Miyano; M Kondo; T Sanke; S Nishimura; K Miyamura; K Inouye; B D Given; S J Chan; K S Polonsky
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.